Analyst firms · Robert W. Baird · VOR

Robert W. Baird VOR price target and rating history

Vor Biopharma Inc. (VOR) · Health Care

Robert W. Baird rates Vor Biopharma Inc. (VOR) Outperform with a $64 price target, as of its latest action on Oct 15, 2025. It has published 3 rating actions on VOR since December 2021, including 1 upgrade and 0 downgrades. Across 4 firms with a VOR price target in the last 12 months, the median target is $40.

Current rating
Outperform
Price target
$64
Median target, all firms
$40
Actions on VOR
3

Robert W. Baird price target on VOR

$64$51$3820222023202420252026
Robert W. Baird price target on VOR, each point a stated target, December 2021 to October 2025.

Every Robert W. Baird rating on VOR

How other firms rate VOR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
William BlairOutperformOct 21, 2026
JefferiesBuy$50Mar 30, 2026
Wells FargoOverweight$30Mar 19, 2026
CitigroupBuy$50Jan 9, 2026
TD CowenBuyDec 17, 2025
WedbushNeutral$9Nov 25, 2025

Questions about Robert W. Baird and VOR

What is Robert W. Baird's price target for VOR?
Robert W. Baird's latest stated price target for Vor Biopharma Inc. (VOR) is $64, from its action on Oct 15, 2025.
What is Robert W. Baird's rating on VOR?
Robert W. Baird rates VOR Outperform, a bullish rating, as of Oct 15, 2025.
When did Robert W. Baird last change its view on VOR?
On Oct 15, 2025, Robert W. Baird upgrades to Outperform from Neutral, price target $64.
How does Robert W. Baird's VOR target compare with other analysts?
Across 4 firms with a VOR price target in the last 12 months, the median target is $40.

All Robert W. Baird ratingsVOR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.